CA1049405A - Methode de diagnostique de l'embolie pulmonaire - Google Patents

Methode de diagnostique de l'embolie pulmonaire

Info

Publication number: CA1049405A
Authority: CA; Canada
Prior art keywords: test method; serum; human; identified; antigen
Prior art date: 1975-05-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA253,011A

Other languages

English (en)

Inventor

Emanuel Silverstein

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-05-20

Filing date

1976-05-20

Publication date

1979-02-27

1976-05-20 Application filed by Individual filed Critical Individual

1979-02-27 Application granted granted Critical

1979-02-27 Publication of CA1049405A publication Critical patent/CA1049405A/fr

Status Expired legal-status Critical Current

Links

208000010378 Pulmonary Embolism Diseases 0.000 title claims abstract description 23
238000010998 test method Methods 0.000 title claims description 18
239000000427 antigen Substances 0.000 claims abstract description 28
102000036639 antigens Human genes 0.000 claims abstract description 27
108091007433 antigens Proteins 0.000 claims abstract description 27
210000004072 lung Anatomy 0.000 claims abstract description 23
210000002966 serum Anatomy 0.000 claims description 38
238000000034 method Methods 0.000 claims description 18
238000006243 chemical reaction Methods 0.000 claims description 15
241001465754 Metazoa Species 0.000 claims description 13
238000002360 preparation method Methods 0.000 claims description 11
241000283973 Oryctolagus cuniculus Species 0.000 claims description 10
230000008105 immune reaction Effects 0.000 claims description 10
238000001962 electrophoresis Methods 0.000 claims description 7
102000004169 proteins and genes Human genes 0.000 claims description 7
108090000623 proteins and genes Proteins 0.000 claims description 7
238000010186 staining Methods 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 6
230000016784 immunoglobulin production Effects 0.000 claims description 4
208000005189 Embolism Diseases 0.000 claims description 3
239000012736 aqueous medium Substances 0.000 claims description 3
150000001720 carbohydrates Chemical class 0.000 claims description 3
238000011534 incubation Methods 0.000 claims description 3
150000002632 lipids Chemical class 0.000 claims description 3
238000003127 radioimmunoassay Methods 0.000 claims description 3
241000282412 Homo Species 0.000 claims description 2
230000000638 stimulation Effects 0.000 claims description 2
230000036647 reaction Effects 0.000 claims 6
210000004369 blood Anatomy 0.000 abstract description 3
239000008280 blood Substances 0.000 abstract description 3
238000001514 detection method Methods 0.000 abstract 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
239000000243 solution Substances 0.000 description 13
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 12
239000000203 mixture Substances 0.000 description 10
239000002244 precipitate Substances 0.000 description 10
239000011780 sodium chloride Substances 0.000 description 10
108010004487 SS-B antigen Proteins 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
229920001817 Agar Polymers 0.000 description 6
239000008272 agar Substances 0.000 description 6
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
238000000760 immunoelectrophoresis Methods 0.000 description 6
229910000160 potassium phosphate Inorganic materials 0.000 description 6
235000011009 potassium phosphates Nutrition 0.000 description 6
238000005119 centrifugation Methods 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
229910052921 ammonium sulfate Inorganic materials 0.000 description 4
235000011130 ammonium sulphate Nutrition 0.000 description 4
230000000890 antigenic effect Effects 0.000 description 4
230000002685 pulmonary effect Effects 0.000 description 4
238000003756 stirring Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
229920002684 Sepharose Polymers 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000002523 gelfiltration Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000000463 material Substances 0.000 description 3
238000002156 mixing Methods 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
229920005654 Sephadex Polymers 0.000 description 2
239000012507 Sephadex™ Substances 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
102100035115 Testin Human genes 0.000 description 2
101710070533 Testin Proteins 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
239000008367 deionised water Substances 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
229940066294 lung surfactant Drugs 0.000 description 2
239000003580 lung surfactant Substances 0.000 description 2
VKWNTWQXVLKCSG-UHFFFAOYSA-N n-ethyl-1-[(4-phenyldiazenylphenyl)diazenyl]naphthalen-2-amine Chemical compound CCNC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 VKWNTWQXVLKCSG-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
238000012216 screening Methods 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
239000010414 supernatant solution Substances 0.000 description 2
HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241000283086 Equidae Species 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241001237728 Precis Species 0.000 description 1
108091006629 SLC13A2 Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
KDXHLJMVLXJXCW-UHFFFAOYSA-J alcian blue stain Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cu+2].[N-]1C(N=C2C3=CC(CSC(N(C)C)=[N+](C)C)=CC=C3C(N=C3C4=CC=C(CSC(N(C)C)=[N+](C)C)C=C4C(=N4)[N-]3)=N2)=C(C=C(CSC(N(C)C)=[N+](C)C)C=C2)C2=C1N=C1C2=CC(CSC(N(C)C)=[N+](C)C)=CC=C2C4=N1 KDXHLJMVLXJXCW-UHFFFAOYSA-J 0.000 description 1
238000012870 ammonium sulfate precipitation Methods 0.000 description 1
JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 1
239000007982 barbital buffer Substances 0.000 description 1
238000007664 blowing Methods 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
238000012754 cardiac puncture Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000003759 clinical diagnosis Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000000227 grinding Methods 0.000 description 1
230000035931 haemagglutination Effects 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
229910052588 hydroxylapatite Inorganic materials 0.000 description 1
230000000951 immunodiffusion Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000007726 management method Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
239000012982 microporous membrane Substances 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1
-1 ~-glucouroni-.. dase Proteins 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Electrochemistry (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA253,011A 1975-05-20 1976-05-20 Methode de diagnostique de l'embolie pulmonaire Expired CA1049405A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US57922275A	1975-05-20	1975-05-20
US68577976A	1976-05-13	1976-05-13

Publications (1)

Publication Number	Publication Date
CA1049405A true CA1049405A (fr)	1979-02-27

Family

ID=27077708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA253,011A Expired CA1049405A (fr)	1975-05-20	1976-05-20	Methode de diagnostique de l'embolie pulmonaire

Country Status (8)

Country	Link
JP (1)	JPS6026979B2 (fr)
BE (1)	BE842041A (fr)
CA (1)	CA1049405A (fr)
DE (1)	DE2622588A1 (fr)
FR (1)	FR2311844A1 (fr)
GB (1)	GB1514639A (fr)
IT (1)	IT1123653B (fr)
NL (1)	NL7605393A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1190853A (fr) *	1981-10-13	1985-07-23	Roberto L. Ceriani	Methode et compose pour le diagnostic des carcinomes

1976
- 1976-05-18 GB GB20507/76A patent/GB1514639A/en not_active Expired
- 1976-05-20 IT IT23449/76A patent/IT1123653B/it active
- 1976-05-20 DE DE19762622588 patent/DE2622588A1/de not_active Withdrawn
- 1976-05-20 CA CA253,011A patent/CA1049405A/fr not_active Expired
- 1976-05-20 JP JP51057335A patent/JPS6026979B2/ja not_active Expired
- 1976-05-20 BE BE167196A patent/BE842041A/fr unknown
- 1976-05-20 FR FR7615196A patent/FR2311844A1/fr active Granted
- 1976-05-20 NL NL7605393A patent/NL7605393A/xx not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB1514639A (en)	1978-06-14
IT1123653B (it)	1986-04-30
DE2622588A1 (de)	1976-12-09
BE842041A (fr)	1976-11-22
FR2311844A1 (fr)	1976-12-17
JPS6026979B2 (ja)	1985-06-26
JPS521016A (en)	1977-01-06
NL7605393A (nl)	1976-11-23
FR2311844B1 (fr)	1979-06-01

Publication	Publication Date	Title
Grabar	1959	Immunoelectrophoretic analysis
Clark et al.	1969	Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus
JP3040162B2 (ja)	2000-05-08	被検体のアッセイを妨害する物質の存在下における生体液中の被検体の測定法
JP3202772B2 (ja)	2001-08-27	ヘリコバクターピロリ検出用の抗原調製物
Manni et al.	1969	The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency
Liebhaber	1970	Measurement of rubella antibody by hemagglutination inhibition: II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum
US4152410A (en)	1979-05-01	Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
Tovey et al.	1984	Standardization of allergens: qualitative definition of house dust mite extracts following electroblotting and detection of components with antibody and lectin probes
US3912805A (en)	1975-10-14	Reagent and assay for human fibrinogen degradation products
Kurup et al.	1988	Isolation and characterization of a relevant Aspergillus fumigatus antigen with IgG-and IgE-binding activity
Magnusson et al.	1992	Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection
Turner et al.	1964	Characterization of human antibodies to Salmonella typhi by gel-filtration and antigenic analysis
Solomon	1969	Molecular heterogeneity of immunoglobulin-M (γM-globulin)
JP3362054B2 (ja)	2003-01-07	扁平上皮がん状物質およびその分離方法
EP0020090B1 (fr)	1984-10-10	Radio-immunoessai pour facteur inhibiteur de migration
Lauf et al.	1969	The M-antigen in HK and LK sheep red cell membranes
Løwenstein et al.	1977	Cladosporium herbarum extract characterized by means of quantitative immunoelectrophoretic methods with special attention to immediate type allergy
DK0454509T3 (da)	1996-11-04	Fremgangsmåde til påvisning af erythrocytagglutination til analyse af blodkompatibiliteter
CA1049405A (fr)	1979-02-27	Methode de diagnostique de l'embolie pulmonaire
US4158049A (en)	1979-06-12	Antigen fraction of Schistosoma mansoni eggs suitable for testing for schistosomiasis
Pine et al.	1977	Procedures for the production and separation of H and M antigens in histoplasmin: chemical and serological properties of the isolated products
CA1127943A (fr)	1982-07-20	Trousse pour le dosage du cholesterol des lipoproteines de faible densite dans les liquides organiques
GB1564063A (en)	1980-04-02	Process for the preparation of -l antibody and -l antigen and preparation and use of reagents containing them
KR920005689B1 (ko)	1992-07-13	혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
BARNHART	1971	Immunologic techniques